StockData
Oncotelic Therapeutics, Inc. logo

Oncotelic Therapeutics, Inc. (OTLC) stock

OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.02+0.00 (+11.45%)

Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –

Oncotelic Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Oncotelic Therapeutics's market cap was $8.45M on Oct 19, 2026, against $39.60M a year earlier. Over the last 5 years it ranged from $7.86M to $93.82M, with a median of $19.30M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$8.45M-73.6%
2025Dec 31, 2025$32.01M+124.6%
2024Dec 31, 2024$14.26M-10.5%
2023Dec 29, 2023$15.93M-18.4%
2022Dec 30, 2022$19.51M-69.2%
2021Dec 31, 2021$63.34M+221.3%
2020Dec 31, 2020$19.71M+38.9%
2019Dec 31, 2019$14.19M+2255.3%
2018Dec 31, 2018$602.47K-16.8%
2017Dec 29, 2017$723.96K-58.3%
2016Dec 30, 2016$1.74M-52.6%
2015Dec 31, 2015$3.67M-39.5%
2014Dec 31, 2014$6.06M+341.1%
2013Dec 31, 2013$1.37M-14.2%
2012Dec 31, 2012$1.60M-39.7%
2011Dec 30, 2011$2.66M–

More Oncotelic Therapeutics figures

See a number that looks wrong?